Aging, heart failure and diabetes each compromise the matching of O 2 delivery (QO 2 )-tometabolic requirements (O 2 uptake, VO 2 ) in skeletal muscle such that the O 2 pressure driving blood-myocyte O 2 flux (microvascular PO 2 , PmvO 2 ) is reduced and contractile function impaired. In contrast, β-guanidinopropionic acid (β-GPA) treatment improves muscle contractile function, primarily in fast-twitch muscle (Moerland and Kushmerick, 1994) . We tested the hypothesis that β-GPA (2% wt/BW in rat chow, 8 wk; n=14) would improve QO 2 -to-VO 2 matching (elevated PmvO 2 ) during contractions (4.5 V @ 1 Hz) in mixed (MG) and white (WG) portions of the gastrocnemius, both predominantly fast-twitch). Compared with control (CON), during contractions PmvO 2 fell less following β-GPA (MG -54%, WG -26%, p<0.05), elevating steadystate PmvO 2 (CON, MG: 10±2, WG: 9±1; β-GPA, MG 16±2, WG 18±2 mmHg, P<0.05). This reflected an increased QO 2 /VO 2 ratio due primarily to a reduced VO 2 in β-GPA muscles. It is likely that this adaptation helps facilitate the β-GPA-induced enhancement of contractile function in fast-twitch muscles.
Introduction
Skeletal muscle fibre types are highly stratified with respect to contraction speed (Armstrong and Phelps, 1984; Baldwin et al., 1972; Barclay et al., 1993; Bottinelli et al., 1996; Delp and Duan, 1996) , oxidative capacity (Delp and Duan, 1996; Gollnick et al., 1972) , capillarity (Folkow and Halicka, 1968) , and O 2 uptake (VO 2 ) kinetics (Barstow et al., 1996) , as well as blood flow (Q) and O 2 delivery (QO 2 ) (Ferreira et al., 2006b ).
Investigation of the mechanistic bases for the heterogeneity of Q and hence QO 2 among muscles of disparate fiber types supports that inter fibre-type differences are attributable, in part, to a differential arteriolar vasomotor control (Behnke et al., 2011; Behnke et al., 2002a; Laughlin et al., 1997; McDonough et al., 2005) .
We have previously demonstrated that, compared with its fast-twitch counterparts (medial and white gastrocnemius, peroneal), the contracting, slow-twitch soleus muscle achieved a higher QO 2 per unit VO 2 (Behnke et al., 2002a; Behnke et al., 2004) . The QO 2 :VO 2 ratio is of crucial importance because it determines the microvascular O 2 partial pressure (PmvO 2 ) which drives blood-myocyte O 2 flux and also helps "set" intracellular PO 2 and thus muscle energetics (Behnke et al., 2002a; Haseler et al., 2004; Hogan and Welch, 1986; McDonough et al., 2005) . The regulation of PmvO 2 demonstrates considerable plasticity, for example, in aging and chronic diseases such as heart failure (Diederich et al., 2002) and diabetes (Behnke et al., 2002c; Padilla et al., 2007) . Specifically, PmvO 2 in the spinotrapezius muscle falls more rapidly and to far lower levels during contractions in aging and these disease states than observed in young healthy controls. Whereas these conditions are associated with slowed pulmonary VO 2 kinetics and compromised muscle oxidative function Behnke et al., 2002c; Belardinelli et al., 1997; Brandenburg et al., 1999; Chilibeck et al., 1997; McDonough et al., 2004a; Pfeifer et al., 2001; Regensteiner et al., 1998; Sietsema et al., 1994) (though see (Wilkerson et al., 2011) for an exception in long-term diabetic patients) the lowered PmvO 2 indicates a reduced QO 2 -to-VO 2 ratio in skeletal muscle.
In addition to depleting intramuscular creatine and phosphocreatine stores (Moerland and Kushmerick, 1994; Moerland et al., 1989) , chronic dietary β-guanidinopropionic acid (β-GPA) treatment up-regulates adenosine monophosphate -activated protein kinase (AMPK) activity (Bergeron et al., 2001; Williams et al., 2009) . AMPK is a serine/threonine kinase that is expressed in several tissues including endothelial and smooth muscle cells and contributes to the regulation of endothelial nitric oxide synthase (eNOS) activation and NO synthesis (Morrow et al., 2003) . Further, Bradley et al. (Bradley et al., 2010) have recently demonstrated that activation of AMPK has a direct vasodilatory action on skeletal muscle resistance arteries through increased NO activity. In muscle-specific AMPK dominant negative transgenic mice there is a faster PmvO 2 decline (i.e., reduced time-constant) during the rest-to-contractions transition versus that observed from mice demonstrating a normal AMPK phenotype (Kano et al., 2011) . Thus, the absence of AMPK induces a disproportionate slowing of QO 2 versus VO 2 kinetics across the rest-to-contractions transition (Kano et al., 2011) . Therefore, long-term β-GPA treatment would likely have an indirect influence on vasomotor regulation (e.g., faster vasodilatory dynamics) through enhanced nitric oxide signaling elicited by increased AMPK activity. Based upon this reasoning, we investigated whether β-GPA treatment would elevate the QO 2 -to-VO 2 ratio during contractions in fast-twitch muscle (which is affected more than slow twitch muscle with β-GPA treatment at least with respect to mitochondrial adaptations (Bruton et al., 2003) ). Specifically, we tested the hypotheses that chronic β-GPA supplementation would reduce the magnitude and slow the rate of the PmvO 2 fall (presumably due to faster blood flow kinetics) during muscular contractions resulting in an elevated steady-state contracting PmvO 2 . As β-GPA treatment improves muscle contractile function primarily in fast-twitch muscle (Moerland and Kushmerick, 1994) , we reasoned that these contractile improvements in fast-twitch muscle would result, in part, from an enhanced PmvO 2 , which would then help facilitate transcapillary O 2 flux and act to increase intramyocyte PO 2 .
Methods
All procedures were approved by the Institutional Animal Care and Use Committee at Kansas State University. Rats were housed individually at 23°C and were maintained on a 12:12-h light-dark cycle. All rats were fed rat chow (control or containing 2% β-GPA for 8 wk, see below) and water ad libitum.
Surgical Preparation
All rats were anesthetized prior to experimentation with pentobarbital sodium (40 mg/kg ip to effect) and supplemented (5-10 mg/kg) as needed. The carotid and tail (caudal) arteries were catheterized with polyethylene tubing (PE-10 connected to PE-50). This allowed for the infusion of the phosphorescent probe [palladium meso-tetra (4-carboxyphenyl) porphine dendrimer (R2)], measurement of arterial blood pressure (Digi-Med BPA model 200, Louisville, KY) and withdrawal of arterial blood for blood gas measurement (Nova Stat Profile M, Waltham, MA).
The muscles used in the current study (i.e., mixed gastrocnemius, (MG) and white gastrocnemius, (WG); (McDonough et al., 2005) ) were chosen as previous research demonstrates that the effects of β-GPA are manifest primarily in fast-twitch musculature (Freyssenet et al., 1995; Moerland, 1995) . Both the MG (3% type I, 6% type IIa, 34% type IId/x and 57% type IIb) and the WG (8 % type IId/x, 92% type IIb; (Delp and Duan, 1996) ) are comprised primarily of fast twitch fiber phenotypes. Whereas the soleus (predominantly slow-twitch) may have provided an interesting 'control' comparison this would have required more animals for what was expected to be a negative result.
Each muscle was exposed for PmvO 2 measurements as previously detailed (McDonough et al., 2005) . The tibial nerve was isolated and a stimulating electrode was attached. The ground electrode was attached distally, near the Achilles tendon. Care was taken to minimize the extent of the surgery in all cases. The exposed tissue was superfused with a Krebs-Henseleit bicarbonate-buffered solution (38°C, equilibrated with 5% CO 2 -N 2 balance) and body temperature was maintained at ~38°C via a heating pad.
β-GPA supplementation
Experimental animals were fed β-GPA for 8 weeks which has been demonstrated to reduce phosphocreatine (PCr) (Moerland and Kushmerick, 1994) and up-regulate AMPK activity (Bergeron et al., 2001; Chaturvedi et al., 2009 ). The β-GPA was incorporated into the rat chow at 2% wt/body wt.
Contractions Protocol
The rat was positioned on a custom-built ergometer and secured as detailed previously (McDonough et al., 2005) . Fifteen minutes later the MG or WG was stimulated at 1-Hz for 3 minutes (twitch 4.5 V, 2 ms pulse duration) using a Grass S88 stimulator. This contraction intensity was chosen as it corresponds to approximately 65% of the voltage which produces a minimal PmvO 2 for these two muscles (McDonough, Behnke, Musch & Poole; Unpublished observations). All animals were euthanized with an overdose of pentobarbital sodium (>80 mg/kg i.a.) following the conclusion of the experimental protocol.
Phosphorescence Quenching
Fifteen minutes prior to the beginning of the contraction protocol the R2 probe was infused (15 mg/kg via the arterial catheter) and the probe of a PMOD 1000 Frequency Domain Phosphorimeter (Oxygen Enterprises Ltd., Philadelphia, PA) was positioned ~2 mm above the exposed muscle. A light guide contained within the probe focuses excitation light (524 nm) on the medial region of the exposed muscle (~2.0 mm diameter, to ~500 μm deep). The PMOD 1000 uses a sinusoidal modulation of the excitation light (524 nm) at frequencies between 100 Hz and 20 kHz, which allows phosphorescence lifetime measurements from 10 μs to ~ 2.5 ms. In the single frequency mode, 10 scans (100 ms) were used to acquire the resultant lifetime of the phosphorescence (700 nm) and repeated every 2 seconds (for review see (Vinogradov and Wilson, 1994) ). The phosphorescence lifetime was obtained computationally based on the decomposition of data vectors to a linearly independent set of exponentials (Moerland et al., 1989) .
The Stern-Volmer relationship allows the calculation of PmvO 2 from a measured phosphorescence lifetime using the following equation:
where k Q is the quenching constant (mmHg/s) and t o and t are the phosphorescence lifetimes in the absence of O 2 and at the ambient O 2 concentration, respectively. For R2, in in vitro conditions similar to those found in the blood, k Q is 409 mmHg −1 .s −1 and t o is 601 μs. Since the R2 is tightly bound to albumin in the plasma and is negatively charged, in combination with the extremely high albumin reflection coefficients in skeletal muscle, the PO 2 measurements are ensured to result from signals within the microvasculature, rather than the surrounding muscle tissue . The phosphorescence lifetime is insensitive to probe concentration, excitation light intensity, and absorbance by other chromophores in the tissue. The effects of pH and temperature are negligible within the normal physiological range which was maintained herein.
Muscle blood flow and oxygen uptake
Muscle blood flow (Q) was measured using the radiolabelled microsphere technique (Musch and Terrell, 1992) at rest and at the end of the 3 minute contraction protocol and expressed as milliliters of blood per minute per 100g tissue (ml.min −1 .100g −1 ). Microspheres (15 μm-diameter; 46 Sc, 85 Sr or 141 Ce; New England Nuclear, Boston, MA) were agitated via sonication and ~5 × 10 5 microspheres were injected into the ascending aorta at the specified time point. Tissue radiation counts were performed using a gamma scintillation counter (Packard Auto Gamma Spectrometer, Cobra model 5003). Adequate distribution of the microspheres was verified with a difference of ≤15% in blood flow between right and left kidneys.
Muscle oxygen uptake (VO 2 ) was calculated as previously described (Behnke et al., 2002b) .
Arterial O 2 content (CaO 2 ) was measured directly (carotid arterial blood) and mixed venous O 2 content (CvO 2 ) was calculated from PmvO 2 (assuming PmvO 2 is a valid approximation of mixed venous PO 2 ; (McDonough et al., 2001 )) using the rat O 2 dissociation curve (constructed using an "n" of 2.6, the measured [Hb], P 50 of 38 mmHg and an O 2 carrying capacity of 1.39 mlO 2 .g Hb −1 ). VO 2 was then calculated via the Fick equation, i.e. VO 2 = Q * (CaO 2 -CvO 2 ).
Citrate synthase measurement
Following the experimental protocol, contralateral (i.e., non-stimulated) muscles were excised rapidly, frozen in liquid N 2 and stored in sealed containers at −80°C until analysis. Citrate synthase activity was measured in duplicate using spectrophotometric analysis from homogenates prepared from the MG and WG muscles according to the methods of Srere (Srere, 1969) . Activity levels were expressed as μmol per minute per gram wet weight.
Curve Fitting and Statistical Analysis
For the PmvO 2 data, curve fitting was accomplished using KaleidaGraph software (version 3.5; Synergy Software, Reading, PA) and was performed on each data set using a onecomponent: or a two-component model:
Where, PmvO 2 (t) is the PmvO 2 at any time t, PmvO 2 (BL) is the baseline pre-contracting PmvO 2 , Δ 1 and Δ 2 are the amplitudes of the PmvO 2 components, TD 1 and TD 2 are the independent time delays and τ 1 and τ 2 are the time constants for each component. Goodness of fit was determined by three criteria: 1. the coefficient of determination (i.e., r 2 ), 2. the sum of the squared residuals, and 3. visual inspection and analysis of the residual fit to a linear model.
The relative rate of change in PmvO 2 (dPO 2 /dt) was defined as the initial Δ PmvO 2 /τ for the on-transient to contractions (McDonough et al., 2004b) . In addition, area under the curve was calculated using the following formula for calculating the area of a trapezoid, AUC = ba + ((b*(c−a))/2, where a = the nadir of PmvO 2 , b = time and c = baseline PmvO 2 . AUC was calculated every 2 s and then summed to obtain a total AUC for the entire contractions protocol.
PmvO 2 values (e.g., baseline, steady-state contracting and delta), modeling dependent (e.g., TD, τ, MRT) results, VO 2 and Q data were analyzed using standard analysis of variance techniques between muscles (MG and WG). When a significant F value was demonstrated by the ANOVA, a Student-Newman-Keuls (SNK) post-hoc test was performed to determine differences among mean values. Pearson product-moment correlations were performed upon select variables. Statistical significance was accepted at P≤0.05.
Results

Body weight and citrate synthase activity
Body weight was significantly reduced in β-GPA vs. CON (275±4 vs. 317±10 g; P<0.05). Citrate synthase was not altered in either MG (MG: 25.9±0.8 vs. 25.7±3.7 μmol.min −1 .g −1 β-GPA vs. CON), or WG (WG: 11.3±0.6 vs. 11.0±0.7 μmol.min −1 .g −1 , both P>0.05 β-GPA vs. CON).
Microvascular PO 2
Representative PmvO 2 responses for both muscles from β-GPA and CON animals are illustrated in Figures 1A & B, respectively. Mean PmvO 2 profiles between groups for each muscle are illustrated in Figure 2 and kinetic parameters described in Table 1 . Mixed Gastrocnemius: No difference was noted for baseline PmvO 2 prior to contractions (Table 1) .
However, the steady-state contracting PmvO 2 was significantly elevated in the β-GPA group. The delta PmvO 2 (i.e., pre-contracting baseline minus steady-state contracting value) was significantly reduced in β-GPA vs. CON (Table 1) . Furthermore, delta PmvO 2 for the secondary component was significantly and directionally different for MG between CON and β-GPA (Table 1 ). In addition, the overall change in PmvO 2 per unit of time (dPO 2 /dt) was significantly slowed for β-GPA (Table 1) , indicative of a slower fall to an elevated steady state baseline. In addition, the area under the curve (a model independent representation of the time taken to achieve a particular steady state) was substantially greater for β-GPA (Table 1) . White Gastrocnemius: Similar to the MG there were no differences in the pre-contracting baseline PmvO 2 in the WG between groups, but the contracting steadystate value was elevated in the β-GPA group. Similar to the results noted for the MG noted above, the overall (dPO 2 /dt) was reduced and the AUC was greater for β-GPA (Table 1) .
Muscle blood flow (Q) and oxygen uptake (VO 2 )
Q was not different between conditions at rest or during contractions in either muscle (Figure 3 ). There was a slight reduction in the calculated resting muscle VO 2 in the WG for β-GPA vs. CON (Figure 4) , and no change in resting VO 2 in the MG. However, contracting VO 2 was significantly reduced in both muscles for β-GPA vs. CON (Figure 4 ).
Discussion
The principal original finding of this investigation is that β-GPA supplementation induces marked changes in the PmvO 2 response to contractions (Figure 1, Table 1 ) within the fasttwitch MG and WG muscles. Specifically, in both the mixed and white portions of the gastrocnemius muscle β-GPA treatment reduced the fall in PmvO 2 with contractions which led to an elevated contracting steady-state PmvO 2 . In addition, PmvO 2 dynamics were slowed in the MG (but not WG) after β-GPA demonstrating an enhanced QO 2 -to-VO 2 ratio across the rest-to-contractions transition. In both muscles these effects enhanced bloodmyocyte O 2 driving pressure (PmvO 2 ) throughout the majority of the on-transient (i.e. AUC was significantly greater in β-GPA). Further, the change in PmvO 2 with β-GPA occurred in the absence of an altered hyperemia; at least during the steady-state of contractions ( Figure  3) . Finally, there was a reduction in the steady-state contracting VO 2 (Figure 4 ) in both muscles, possibly indicating an enhanced efficiency of muscular contractions, which has been demonstrated previously following experimental creatine depletion (Moerland and Kushmerick, 1994) . Thus, in many respects β-GPA transformed the PmvO 2 profile in these fast-twitch muscles such that the qualitative responses were similar to that of slow-twitch muscle (see (McDonough et al., 2005) . Interestingly, the slowed PmvO 2 response and elevated contracting steady-state PmvO 2 occurred in the absence of an elevated oxidative capacity (i.e., no change in citrate synthase activity for either muscle). These results indicate that, following experimental creatine depletion via β-GPA, the ratio of QO 2 /VO 2 is raised during contractions, indicative of an overall enhancement of muscle O 2 availability which may contribute to the improved oxidative and contractile function demonstrated for this condition (Moerland and Kushmerick, 1994) .
β-GPA and PmvO 2 dynamics
In β-GPA PmvO 2 dynamics were slowed (↓dPO 2 /dt) and the AUC was greater indicating that QO 2 responded with faster dynamics than VO 2 , across the rest-to-contractions transition (Table 1) . Whereas we did not measure Q or VO 2 dynamics in separatum, based upon the modeling of Diederich et. al. (Haseler et al., 2004) with β-GPA compared to control, the slower PmvO 2 dynamics could arise from either: 1) a faster increase in Q (and hence QO 2 ) relative to VO 2 , 2) slower QO 2 and VO 2 dynamics but with a greater proportional slowing of the VO 2 response, or 3) a similar QO 2 response but slower VO 2 kinetics. According to Meyer's electrical analog model of mitochondrial respiratory control (Meyer, 1988 ; as recently validated in vitro by Glancy et al. 2008): where Rm is the mitochondrial resistance to energy transfer and C is the metabolic capacitance of the total creatine pool (i.e., PCr + Cr). In the present investigation, Rm as reflected by oxidative enzyme capacity, would be unchanged (as also found for superficial and mixed gastrocnemius by Shoubridge et al. (1985) ) but β-GPA would act to reduce C, thereby speeding VO 2 kinetics (reduced τVO 2 ) and refuting options 2 and 3 above. In contrast, there is a wealth of experimental evidence supporting that impediments to the CK reaction evoked either by MM creatine kinase knockout (Roman et al. 2002) or by stripping CK of useable substrate (β-GPA, Moerland and Kushmerick, 1994; iodoacetamide, Kindig et al. 2005) lead to a faster increase of ADP free and VO 2 during contractions (Freyssenet et al., 1995; Moerland and Kushmerick, 1994) . Thus the CK reaction (and its ability to temporally buffer ATP levels) may be a large component of the "lag" in VO 2 (i.e., finite VO 2 kinetics) following the onset of contractions. In accord with option 1 above, several lines of evidence support faster QO 2 dynamics with β-GPA. Specifically, β-GPA supplementation up-regulates AMPK activity (Bergeron et al., 2001 ) even in the absence of increased oxidative capacity/mitochondrial volume (Williams et al., 2009) ). The pleiotropic effects of AMPK include increased endothelial NO synthase (eNOS) activation (Chen et al., 2009; Chen et al., 1999) and inhibition of NADPH oxidase activity (Schulz et al., 2008) , both of which may increase the bioavailability of NO. In addition, activation of AMPK enhances resistance artery vasodilation via activation of eNOS (Bradley et al., 2010) .
Therefore, during conditions of increased vascular shear-stress (e.g., onset of contractions), a greater production (and bioavailability) of endothelium-derived NO would be expected in the β-GPA group, which may act to accelerate the QO 2 response during contractions. In the current study, the fall in PmvO 2 was slowed and the contracting steady-state elevated in the β-GPA group with no difference PmvO 2 between groups at rest. Accordingly, the altered PmvO 2 response with contractions indicates that any augmentation of NO bioavailability in the β-GPA group would have greater effects during contractions versus rest. Indeed, increasing NO bioavailability in healthy skeletal muscle does not alter resting PmvO 2 , but does slow the PmvO 2 response across the rest-exercise transition (Ferreira et al., 2006a; Ferreira et al., 2006c) , suggesting an enhanced QO 2 relative to VO 2 during the exercise ontransient and the steady-state (Figures 2-4 ).
Effects of β-GPA on the O 2 Delivery (QO 2 ) Oxygen Uptake (VO 2 ) Relationship
In healthy control muscles, there exists a strong linear relationship between VO 2 and QO 2 such that increased QO 2 is driven by an elevated Q-to-VO 2 ratio (typically 5-6 L Q/L VO 2 . The unchanged steady-state Q (Figure 3 , and therefore QO 2 ) in the face of decreased VO 2 (Figure 4) indicates that β-GPA changed the fundamental relationship between VO 2 and Q.
A β-GPA-induced reduction in the steady-state energy cost (i.e., increased efficiency) of contractions is a consistent finding (Moerland and Kushmerick, 1994) , (Shoubridge and Radda, 1984) . In the absence of increased mitochondrial oxidative capacity one putative mechanism for the elevated contractile efficiency herein is the elevated PmvO 2 which would act to increase intramyocyte PO 2 and thereby reduce disturbance of the intracellular milieu (Wilson et al., 1977) . Furthermore, this effect would be in addition to faster VO 2 kinetics which in itself would allow a given VO 2 to be achieved with less change in phosphatelinked controllers of mitochondrial function (i.e., Δ[PCr], [ADP f ], [Pi] ). Within contracting skeletal muscle, conditions expected to elevate PmvO 2 (and by extension intracellular PO 2 ) at a given power output (e.g., hyperoxia, (Macdonald et al., 1997; Wilkerson et al., 2006) ; respiratory muscle unloading, (Cross et al., 2010) ) reduce the VO 2 cost by lowering the socalled VO 2 slow component (rev. (Poole et al., 2008) ). The VO 2 slow component represents a high phosphate (ATP) cost of force production and hence there is a tight relationship between PCr, Pi and VO 2 as the VO 2 slow component increases VO 2 (Dimenna et al., 2010; Rossiter et al., 2002; Rossiter et al., 2003) . Therefore, potential mechanisms by which βGPA might reduce VO 2 relate to reduced ΔPCr and ΔPi either consequent to the direct effects of βGPA or, alternatively, by increasing the QO 2 /VO 2 ratio and elevating PmvO 2 and thus intracellular PO 2 .
It is pertinent to note that exercise training also facilitates this 'tighter' metabolic control. While β-GPA achieves this through a decrease in the total usable creatine pool ("C" in Meyer's model; see above), exercise training will typically result in an increased mitochondrial enzyme activity (or decreased Rm in Meyer's model) (Phillips et al., 1996) in addition to improvements in capillarity that will enhance blood-myocyte O 2 transport (Saltin and Gollnick, 1983; Poole et al. 1989; Poole and Mathieu-Costello, 1990 ). Thus, while β-GPA results in faster VO 2 kinetics, the mechanism is different than that achieved through exercise training
Directions for future research
This study raises several intriguing possibilities that could usefully be addressed in future investigations using the β-GPA intervention. These include determining whether: 1. β-GPA supplementation alters the dynamics of resistance artery vasodilation, 2) despite an unaltered CS activity, biochemical adaptations in mitochondrial phenotype (i.e., intermyofibrillar versus subsarcolemmal) elicited by creatine depletion (Roussel et al., 2000) alter the "metabolic work" of the muscle due to the differential bioenergetics behaviors of distinct mitochondrial populations (Cogswell et al., 1993) and impact the VO 2 per unit work/tension (i.e., efficiency), 3) the heterogeneity of QO 2 is reduced and/or its speed increased with β-GPA treatment (likely through an AMPK mediated pathway ) during exercise. Addressing these possibilities may provide important insight into how alterations in the creatine kinase and/or AMPK pathways might contribute to oxidative and contractile function in skeletal muscle.
Conclusions
In the two fast-twitch skeletal muscles utilized in the current study (i.e., the mixed and superficial white portion of the gastrocnemius muscle) β-GPA supplementation induced significant changes in matching of QO 2 -to-VO 2 during the rest-to-contractions transition, including a slower dPmvO 2 /dt (MG) and an elevated contracting steady-state PmvO 2 (MG and WG). Further, despite an unaltered steady-state contracting Q between groups, β-GPA supplementation resulted in a lower contracting VO 2 in both muscles versus their controls. Interestingly, the altered PmvO 2 profile and reduced VO 2 occurred in the absence of any changes in citrate synthase activity (marker of oxidative capacity) but, with respect to the dynamic matching of QO 2 and VO 2 , make these fast-twitch muscles resemble slow twitch muscles (e.g., soleus, Behnke et al. 2003; McDonough et al. 2005) .
Highlights
• In this study we examined the effects of experimental creatine depletion on muscle oxygenation, blood flow and O 2 uptake.
• We contracted fast-twitch muscle in control and animals that consumed beta-GPA to deplete creatine stores.
• We found that beta-GPA enhanced muscle oxygenation across the rest-tocontractions transition.
• We also found that blood flow was not different between groups, but contracting O 2 uptake was reduced in the beta-GPA group.
• We conclude that experimental creatine depletion enhances muscle microvascular oxygenation which may lead to enhanced contractile performance in fast-twitch muscle. Microvascular O 2 partial pressure (PmvO 2 ) responses for the mixed (MG) and white gastrocnemius (WG) from representative animals in A) control and B) β-GPA groups following the onset of 1 Hz contractions (time 0). Note that while baseline PmvO 2 is not different between muscles or conditions, β-GPA supplementation significantly increased the steady state contracting PmvO 2 . The thin line is the measured PmvO 2 value whereas the smoothed line is the model-fit of the response. Mean microvascular O 2 partial pressure (PmvO 2 ) profiles from control and β-GPA treated animals across the rest-to-contractions transition in the A) mixed gastrocnemius and B) white gastrocnemius. Contractions were initiated at time zero. Average kinetic parameters are described in Table 1 . Muscle blood flow (Q) in the A) mixed and B) white portions of the gastrocnemius muscle at rest (i.e., immediately prior to the onset of contractions) and during the steady-state of contractions (i.e., 3 min after the onset of contractions) in both control and β-GPA groups. * denotes significantly higher Q compared to MG (p<0.05). Calculated muscle oxygen uptake (VO 2 ) in the A) mixed and B) white portions of the gastrocnemius muscle at rest (i.e., immediately prior to the onset of contractions) and during the steady-state of contractions (i.e., 3 min after the onset of contractions) in both control and β-GPA groups. * denotes significantly different compared to MG for the same condition (p<0.05). # P<0.05 versus control group.
